Login / Signup

Efficacy and safety of peginterferon alpha monotherapy in Chinese inactive chronic hepatitis B virus carriers.

Fengping WuRui LuYixin LiuYikai WangYan TianYaping LiMei LiWenjun WangXin ZhangXiaoli JiaShuangsuo Dang
Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Peg-IFN-α monotherapy results in high rates of HBsAg clearance and seroconversion and the treatment is safe for IHCs.
Keyphrases
  • hepatitis b virus
  • combination therapy
  • liver failure
  • open label
  • immune response
  • clinical trial
  • randomized controlled trial
  • double blind